We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PLPL market cap is 15.21k. The company's latest EPS is USD -0.1952 and P/E is 0.00.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | 0 | -130k | -18k | -706k |
| Net Income | -102k | -83k | -69k | 12.77M | -19.8M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.26M | 7.26M | 7.26M | 0 | 0 |
| Total Liabilities | 26.14M | 26.24M | 25.16M | 421k | 443k |
| Total Equity | -18.88M | -18.98M | -17.9M | -421k | -443k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | -130k | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | 130k | N/A | N/A |
| Market Cap | 15.21k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 101.42M |
| Average Volume (1 week) | 10.63M |
| Average Volume (1 Month) | 36.54M |
| 52 Week Change | -62.50% |
| 52 Week High | 0.0007 |
| 52 Week Low | 0.000098 |
| Spread (Intraday) | 0.25 (99.96%) |
| Company Name | Plandai Biotechnology Inc (PK) |
| Address |
416 w san ysidro blvd las vegas, nevada 89118 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
